abstract |
The present invention relates to chemokine receptor binding compounds, pharmaceutical compositions and uses thereof. More specifically, the present invention relates to activity modulators of chemokine receptor activity, preferably CCR5 activity modulators. These compounds show a protective effect against infection of target cells by human immunodeficiency virus (HIV). |